Science & Technology
We are leveraging our proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections and other serious diseases.
ImmunoTAC® PLATFORM
Our ImmunoTAC platform combines systemic and tissue-targeted delivery, allowing us to transport disease-modifying small molecules directly to the site of a patient’s disease.